Smart sensors could revolutionize how we track FTD symptoms

NCT ID NCT07333898

Not yet recruiting Knowledge-focused Sponsor: BioSensics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether wearable sensors and computerized voice and thinking tests can reliably track symptoms in people with frontotemporal dementia (FTD). Twenty participants will wear sensors and complete assessments at home over 12 months. The goal is to develop digital biomarkers that could help monitor disease progression in future trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORTICOBASAL DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Corticobasal Degeneration corticobasal degeneration disorder corticobasal syndrome frontotemporal dementia Frontotemporal Lobar Degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.